Computerized Extraction of Electrocardiograms From Continuous 12‐Lead Holter Recordings Reduces Measurement Variability in a Thorough QT Study
暂无分享,去创建一个
P. Sager | I. Gussak | Ignacio Rodriguez | Samuel E. George | Ignacio Rodriguez | D. Ipe | Philip T. Sager | Ihor Gussak | Branislav Vajdic | Samuel George | D. Ipe | B. Vajdic
[1] Joanne Zhang. Testing for Positive Control Activity in a Thorough QTc Study , 2008, Journal of biopharmaceutical statistics.
[2] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[3] P. Kowey,et al. Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects. , 2009, Journal of electrocardiology.
[4] Alex Dmitrienko,et al. Sample Size Calculations in Thorough QT Studies , 2008, Journal of biopharmaceutical statistics.
[5] Borje Darpo,et al. Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods , 2004, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[6] B. Tyl,et al. Comparison of Semiautomated and Fully Automated Methods for QT Measurement During a Thorough QT/QTc Study: Variability and Sample Size Considerations , 2009, Journal of clinical pharmacology.
[7] B. Darpo,et al. Comparison of Manual and Automated Measurements of the QT Interval in Healthy Volunteers: An Analysis of Five Thorough QT Studies , 2009, Clinical pharmacology and therapeutics.
[8] Charles Ho,et al. Advances in ambulatory monitoring: regulatory considerations. , 2004, Journal of electrocardiology.
[9] Stella G. Machado,et al. Statistical Issues Including Design and Sample Size Calculation in Thorough QT/QTc Studies , 2008, Journal of biopharmaceutical statistics.
[10] Joel Morganroth,et al. A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment. , 2004, Journal of electrocardiology.
[11] J. Ruskin,et al. The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. , 2005, Journal of the American College of Cardiology.
[12] F. Badilini,et al. Implications of methodological differences in digital electrocardiogram interval measurement. , 2006, Journal of electrocardiology.
[13] Borje Darpo,et al. THEMED SECTION: QT SAFETY REVIEW The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance , 2010 .
[14] D. Altman,et al. Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.
[15] D. Karnad,et al. Effect of Number of Replicate Electrocardiograms Recorded at Each Time Point in a Thorough QT Study on Sample Size and Study Cost , 2011, Journal of clinical pharmacology.
[16] Automatic Extraction of ECG Strips from Continuous 12‐lead Holter Recordings for QT Analysis at Prescheduled versus Optimized Time Points , 2009, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[17] G. Koch,et al. Sample Size Calculations for Crossover Thorough QT Studies: Satisfaction of Regulatory Threshold and Assay Sensitivity , 2010, Journal of biopharmaceutical statistics.
[18] J M Bland,et al. Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .
[19] Lawrence J Hickey,et al. The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies , 2008, Clinical pharmacology and therapeutics.
[20] H. Lepor,et al. Effects of the Selective α1A‐Adrenoceptor Antagonist Silodosin on ECGs of Healthy Men in a Randomized, Double‐Blind, Placebo‐ and Moxifloxacin‐Controlled Study , 2010, Clinical pharmacology and therapeutics.
[21] B. Tyl,et al. Detection of Clinically Significant QTc Prolongation in Phase I Studies in Healthy Participants: Comparison of 2 Semiautomated QT Measurement Methods , 2009, Journal of clinical pharmacology.
[22] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[23] S. Rohatagi,et al. Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs , 2009, Journal of clinical pharmacology.